Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial
Journal of Nuclear Medicine · 2026-01 · 67 (1) · 60-66
DOI: 10.2967/jnumed.125.271344 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 06.11.2025. Verfasst von Philipp Krausewitz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antigens, Surface. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de.
- Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
- Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
- Institute of Pathology, University Hospital Bonn, Bonn, Germany.
- Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and.
- Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
Zitieren
APA
Krausewitz, P., Essler, M., Gaertner, F. C., Attenberger, U., Luetkens, J. A., Kristiansen, G., Bernhardt, M., Ohlmann, C. H., Anspach, M., Schmid, M., Nemeth, R., Schmitz, J., Hauser, S., Ellinger, J., & Ritter, M. (2026). Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Journal of Nuclear Medicine, 67(1), 60-66. https://doi.org/10.2967/jnumed.125.271344
Vancouver
Krausewitz P, Essler M, Gaertner FC, Attenberger U, Luetkens JA, Kristiansen G, et al. Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Journal of Nuclear Medicine. 2026;67(1):60-66. doi:10.2967/jnumed.125.271344
BibTeX
@article{Krausewitz2026,
author = {Krausewitz, Philipp and Essler, Markus and Gaertner, Florian C and Attenberger, Ulrike and Luetkens, Julian A and Kristiansen, Glen and Bernhardt, Marit and Ohlmann, Carsten-Henning and Anspach, Michael and Schmid, Matthias and Nemeth, Robert and Schmitz, Jennifer and Hauser, Stefan and Ellinger, Joerg and Ritter, Manuel},
title = {Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial},
journal = {Journal of Nuclear Medicine},
year = {2026},
volume = {67},
number = {1},
pages = {60--66},
doi = {10.2967/jnumed.125.271344}
}
EUVIMED